Home・Akcijų sąrašas・Abbott Laboratories

Abbott Laboratories

Uždarymo kaina

SektoriusSveikatos priežiūra

109.68 0.91

Pirkti Parduoti

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

108

Max

110.11

Pagrindiniai rodikliai
By Trading Economics
Pajamos	-149M 928M
Pardavimai	1.4B 13B
P/E Sektoriaus vid.	34.667 68.51
Pelnas, tenkantis vienai akcijai	1.31
Dividendų pajamingumas	2.35
Pelno marža	7.369
Darbuotojai	122,000
EBITDA	-465M 1.8B

Rekomendacijos
By TipRanks
Rekomendacijos	Stiprus pirkimas
12 mėnesių prognozė	+11.24% upside

Dividendai
By Acuity
Dividendų pajamingumas Sektoriaus vid.	2.35% 2.29%
Kitas uždarbis	2026-10-14
Kitas dividendų mokėjimo data	2026-08-17
Kita Ex Dividend data	2026-10-14

Rinkos statistika
By TradingEconomics
Rinkos kapitalizacija	23B 187B
Ankstesnė atidarymo kaina	108.77
Ankstesnė uždarymo kaina	109.68

Abbott Laboratories Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-08-11 19:16; UTC

News

Abbott Laboratories announced a partnership with Google Health to enhance glucose management through AI. Shares are trading higher amid positive market sentiment.

2026-08-10 23:46; UTC

Abbott Laboratories shares are lower in after-market hours, with no specific news identified for the decline. The stock remains above its 20-day moving average.

2026-08-07 23:06; UTC

Abbott Laboratories shares declined slightly in after-market trading. The stock remains above its 20-day moving average and near the upper end of its one-month range.

2026-08-06 23:01; UTC

Abbott Laboratories shares are lower in after-market hours, amid broader market weakness and rising initial jobless claims contributing to tightening expectations.

2026-08-05 23:02; UTC

Abbott Laboratories shares are lower in after-market trading, following a brief peak post-close. Broader market conditions may be influencing sentiment amid weaker U.S. job growth data.

2026-08-04 20:06; UTC

Abbott Laboratories shares are lower today, tracking broader market declines amid falling crude oil prices and ongoing discussions about potential peace talks.

2026-08-03 23:06; UTC

Abbott Laboratories shares are near unchanged in after-market trading, positioned 7.52% above the 20-day moving average and near the upper end of the one-month range.

2026-07-31 23:01; UTC

Abbott Laboratories shares are modestly higher in after-market trading. The stock remains elevated, 7.16% above its 20-day moving average.

2026-07-30 23:51; UTC

Abbott Laboratories shares are higher in after-market trading, recovering from earlier losses. The stock trades significantly above its 20-day moving average.

2026-07-29 23:01; UTC

Abbott Laboratories shares are lower in after-market hours, continuing recent volatility amid mixed global market performance and rising geopolitical tensions in the Middle East.

2026-07-28 23:02; UTC

Abbott Laboratories shares are higher in after-market hours, showing notable volatility post-close while remaining above the 20-day moving average. No specific news was identified.

2026-07-27 23:02; UTC

Abbott Laboratories shares are lower in after-market hours, with no specific news identified to explain the movement. Broader market sentiment may be influencing the decline.

2026-07-24 20:02; UTC

News

A court dismissed a shareholder lawsuit regarding Abbott Laboratories' 2022 infant formula recall, boosting market sentiment as shares trade higher with increased volume.

2026-07-23 23:41; UTC

Abbott Laboratories shares are lower in after-market hours amid broader market weakness, particularly in the bond market, with no specific company news identified.

2026-07-22 22:06; UTC

Abbott Laboratories shares are higher in after-market trading, positioned above their 20-day moving average and near the upper end of their one-month trading range.

2026-07-21 19:01; UTC

Abbott Laboratories is lower today, continuing a decline that began Monday. The stock has dropped from an early peak amid no specific news.

2026-07-20 23:06; UTC

Abbott Laboratories shares are lower in after-market hours, with no specific news identified. Broader market volatility stems from rising Treasury yields and geopolitical tensions.

Akcijų palyginimas

Kainos pokytis

Abbott Laboratories Prognozė

Kainos tikslas

By TipRanks

11.24% į viršų

12 mėnesių prognozė

Vidutinis 120.83 USD 11.24%

Aukščiausias 135 USD

Žemiausias 112 USD

Remiantis 15 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Abbott Laboratories kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Stiprus pirkimas

15 ratings

Pirkti

Laikyti

Parduoti

Remiantis 15 analitikų, pateikusių Abbott Laboratories akcijų reitingus – Dist per pastaruosius 3 mėnesius.

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

Apie bendrovę Abbott Laboratories

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also offers laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for laboratories. In addition, the company provides pediatric and adult nutritional products; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.